NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/06/2026
Back to search
Official data from USPTO
HIPSCORE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
01/06/2026
Trademark type
Word
Nice classes
5, 42
Filing date
08/07/2024
Registration date
01/06/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/06/2026
Last transaction
01/06/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
16
Owner location
Düsseldorf, DE
Examiner
DIGAN, MATTHEW M
Law office
N60
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
IUF Leibniz-Institut für umweltmedizinische Forschung GmbH
IUF Leibniz-Institut für umweltmedizinische Forschung GmbH
Representatives
Gerard T. Gallagher Barnes & Thornburg LLP
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Tissues for surgical use being surgical implants comprised of living tissues based on human induced pluripotent stem cells; diagnostic agents and materialsamplification primers for amplifying a gene specific for mesodermal cells or a part of a gene specific for mesodermal cells for medical and pharmaceutical usein particularfor the analysis of human-induced pluripotent stem cells; diagnostic agents and materialsamplification primers for amplifying a gene specific for mesodermal cells or a part of a gene specific for mesodermal cells for medical and pharmaceutical use using human-induced pluripotent stem cells; diagnostic agents and materialsamplification primers for amplifying a gene specific for endodermal cells or a part of a gene specific for endodermal cells for medical and pharmaceutical usein particularfor the analysis of human-induced pluripotent stem cells; diagnostic agents and materialsamplification primers for amplifying a gene specific for endodermal cells or a part of a gene specific for endodermal cells for medical and pharmaceutical use using human-induced pluripotent stem cells; diagnostic agents and materialsamplification primers for amplifying a gene specific for ectodermal cells or a part of a gene specific for ectodermal cells for medical and pharmaceutical usein particularfor the analysis of human-induced pluripotent stem cells; diagnostic agents and materialsamplification primers for amplifying a gene specific for ectodermal cells or a part of a gene specific for ectodermal cells for medical and pharmaceutical use using human-induced pluripotent stem cells; diagnostic agents and materialsamplification primers for amplifying a gene specific for pluripotent cells or a part of a gene specific for pluripotent cells for medical and pharmaceutical usein particularfor the analysis of human-induced pluripotent stem cells; diagnostic agents and materialsamplification primers for amplifying a gene specific for pluripotent cells or a part of a gene specific for pluripotent cells for medical and pharmaceutical use using human-induced pluripotent stem cells
Class 42
Scientific and technological services;scientific researchanalysistestingevaluation in the field of human-induced pluripotent stem cells; Scientific and technological servicestesting in the field of human-induced pluripotent stem cells; authentication in the field of human-induced pluripotent stem cells; quality control for others in the field of human-induced pluripotent stem cells
Publications
History of USPTO decisions and trademark events.
25 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
01/06/2026
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/24/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
11/24/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
11/24/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/18/2025
PUBO
PUBLISHED FOR OPPOSITION
11/18/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/12/2025
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
09/16/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/26/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
08/26/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/26/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
08/26/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/26/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/12/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/12/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/12/2025
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
05/12/2025
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
05/12/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/13/2025
GNRT
NON-FINAL ACTION E-MAILED
02/13/2025
CNRT
NON-FINAL ACTION WRITTEN
02/13/2025
DOCK
ASSIGNED TO EXAMINER
02/12/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/22/2025
NWAP
NEW APPLICATION ENTERED
08/07/2024
Continuous trademark protection
Get notified about every new filing that threatens HIPSCORE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.